The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results